FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Parabilis Medicines, Inc.
Coherus Oncology, Inc.
Astellas Pharma Inc
AstraZeneca
Astellas Pharma Inc
GlaxoSmithKline
Tyligand Pharmaceuticals (Suzhou) Limited
UNICANCER
UNICANCER
Leap Therapeutics, Inc.
Jazz Pharmaceuticals
NuCana plc
Pfizer
DEKA Biosciences
Ukrainian Society of Clinical Oncology
Tyme, Inc
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Boston Scientific Corporation
Tarveda Therapeutics
AbbVie
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Eli Lilly and Company
Gilead Sciences
Amgen
Georgetown University
Washington University School of Medicine
Hellenic Oncology Research Group
University of California, San Francisco
Galectin Therapeutics Inc.
H. Lee Moffitt Cancer Center and Research Institute
Merrimack Pharmaceuticals
University of Utah
H. Lee Moffitt Cancer Center and Research Institute
Valerio Therapeutics
Eli Lilly and Company
OHSU Knight Cancer Institute
Galectin Therapeutics Inc.
AstraZeneca
Mast Therapeutics, Inc.
Southwestern Regional Medical Center
Seattle Cancer Treatment and Wellness Center